Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Res ; 89(5): 1253-1260, 2021 04.
Article in English | MEDLINE | ID: mdl-32663837

ABSTRACT

BACKGROUND: Antenatal glucocorticoids (GCs) reduce respiratory distress syndrome (RDS) in preterm infants and are associated with reduced lung liquid content. Our aim was to assess whether airway gene expression of mediators of pulmonary epithelial sodium and liquid absorption, and further, respiratory morbidity, associate with cord blood GC concentrations. METHODS: The study included 64 infants delivered <32 weeks gestation. Cortisol and betamethasone in umbilical cord blood were quantified with liquid chromatography-tandem mass spectrometry. The total GC concentration was calculated. Gene expression of the epithelial sodium channel (ENaC), Na,K-ATPase, and serum- and GC-inducible kinase 1 at <2 h and at 1 day postnatally in nasal epithelial cell samples was quantified with reverse transcription-polymerase chain reaction. The mean oxygen supplementation during the first 72 h was calculated. RESULTS: Concentrations of cord blood betamethasone and total GC were significantly lower in infants with RDS and correlated with mean oxygen supplementation. Expression of αENaC and α1- and ß1Na,K-ATPase at <2 h correlated with betamethasone and total GC concentrations. Expression of Na,K-ATPase was lower in infants with RDS. CONCLUSION: Enhancement of lung liquid absorption via increased expression of sodium transporters may contribute to the beneficial pulmonary effects of antenatal GCs. IMPACT: RDS is related to lower umbilical cord blood GC concentrations and lower airway expression of sodium transporters. In addition to the timing of antenatal GC treatment, resulting concentrations may be of importance in preventing RDS. Induction of sodium transport may be a factor contributing to the pulmonary response to antenatal GCs.


Subject(s)
Betamethasone/chemistry , Glucocorticoids/metabolism , Respiratory Distress Syndrome, Newborn/physiopathology , Sodium/chemistry , Biological Transport , Cross-Sectional Studies , Epithelial Sodium Channels/genetics , Female , Fetal Blood/metabolism , Gene Expression Profiling , Humans , Infant , Infant, Newborn , Infant, Premature , Male , Prospective Studies , Sodium-Potassium-Exchanging ATPase/metabolism
2.
Mol Cell Neurosci ; 35(1): 1-13, 2007 May.
Article in English | MEDLINE | ID: mdl-17321752

ABSTRACT

Mutations in SPG3A causing autosomal dominant pure spastic paraplegia led to identification of atlastin, a new dynamin-like large GTPase. Atlastin is localized in the endoplasmic reticulum, the Golgi, neurites and growth cones and has been implicated in neurite outgrowth. To investigate whether it exerts its activity in the early secretory system, we expressed normal and mutant atlastin in cell culture. Pathogenic mutations in the GTPase domain interfered with the maturation of Golgi complexes by preventing the budding of vesicles from the endoplasmic reticulum, whereas mutations in other regions of the protein disrupted fission of endoplasmic reticulum-derived vesicles or their migration to their Golgi target. Atlastin, therefore, plays a role in vesicle trafficking in the ER/Golgi interface. Furthermore, atlastin partially co-localized with proteins of the p24/emp/gp25L family that regulate vesicle budding and trafficking in the early secretory pathway, and co-immunoprecipitated p24, suggesting a functional relationship that should be further explored.


Subject(s)
Cytoplasmic Vesicles/enzymology , Endoplasmic Reticulum/enzymology , GTP Phosphohydrolases/genetics , GTP Phosphohydrolases/metabolism , Golgi Apparatus/enzymology , Motor Neurons/enzymology , Adult , Cell Line , Cytoplasmic Vesicles/ultrastructure , Endoplasmic Reticulum/ultrastructure , Epitopes , GTP-Binding Proteins , Golgi Apparatus/ultrastructure , Humans , Kidney/cytology , Membrane Proteins , Microscopy, Electron , Motor Cortex/cytology , Paraplegia/genetics , Paraplegia/metabolism , Point Mutation , Protein Transport/physiology , Spinal Cord/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...